Cholesterol obtains the category for “extreme risk” in a new guideline

Document with guidelines guidelines was released on Wednesday 24, by the Brazilian Society of Cardiology (SBC)

The Brazilian Society of Cardiology (SBC) announced on Wednesday 24, a series of guidelines that update the guidelines of the dyslipidemia and the prevention of the atherosclerosis. Among the main changes there is the hardening of the LDL objectives, known as “bad cholesterol”.

• Receive the main news directly on WhatsApp! Sign up for the Earth channel

For the first time, there is a corresponding category for an extreme risk, whose goal is <40 mg/dl. According to the document, signed by over 20 experts, it focuses on patients who have had multiple cardiovascular events.

New LDL objectives:

• Bass: <115 mg/dl
• Intermediate: <100 mg/dl
• High: <70 mg/dl
• Very high: <50 mg/dl
• Extreme: <40 mg/dl (non -existent category in the previous guideline)

It is worth remembering that the guidelines are valid for consultation Doctor, by a specialist.

According to SBC, the new guidelines updates and expands the concepts of the 2017 version, maintaining attention on the stratification of the risk. “The current and well -designed guidelines, like this, constitute a fundamental tool to achieve the objective of reducing the impact of cardiovascular disease (DCV) and, in this particular case, atherosclerotic disease (DCVA)”, says the document.

“Attention is paid to the continuum of cardiovascular risk, starting from the early and accurate identification of aggravating factors – as a family history of cardiovascular diseases and premature obesity, among others – and advancing the progressive stratification to very high and extreme risk levels of risk, where the therapeutic approach should be more intense”, underlines.

Another change is the recommendation of combined therapy as a treatment line for these groups, with the use of statins associated with Ezetimiba, anti-PCSK9 therapies and wellpective acid, especially in cases of statin intolerance or need for a reduction in additional cardiovascular risk (CV). In addition to the structured management of intolerance statins.

Source: Terra

Ben

Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.